TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs17685
log Bayes Factor = 0.0213159
Chromosome 7   position 75,616,105  (GRCh37) Explore rs17685 on Ensembl!
Variant rs17685 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
M17.9 Gonarthrosis, unspecified
0.094 0.906 0.000
F10.2 Dependence syndrome
0.000 0.919 0.081
F10 Mental and behavioural disorders due to use of alcohol
0.000 0.920 0.080
F10.1 Harmful use
0.000 0.923 0.077
F10.0 Acute intoxication
0.000 0.926 0.074
F10.3 Withdrawal state
0.000 0.928 0.072
F10.6 Amnesic syndrome
0.000 0.933 0.067
F10.4 Withdrawal state with delirium
0.000 0.939 0.061
F10.8 Other mental and behavioural disorders
0.000 0.942 0.058
F10.5 Psychotic disorder
0.000 0.943 0.057
F10.7 Residual and late-onset psychotic disorder
0.000 0.949 0.051
F10.9 Unspecified mental and behavioural disorder
0.000 0.955 0.044
T40.2 Other opioids
0.000 0.978 0.022
H61.0 Perichondritis of external ear
0.000 0.980 0.020
J33.0 Polyp of nasal cavity
0.000 0.980 0.020
J33.8 Other polyp of sinus
0.000 0.981 0.019
J33 Nasal polyp
0.000 0.982 0.018
F10-F19 Mental and behavioural disorders due to psychoactive substance use
0.000 0.983 0.017
J34.8 Other specified disorders of nose and nasal sinuses
0.000 0.986 0.014
J32.0 Chronic maxillary sinusitis
0.000 0.986 0.014
J32 Chronic sinusitis
0.000 0.986 0.014
J30-J39 Other diseases of upper respiratory tract
0.000 0.987 0.013
F11 Mental and behavioural disorders due to use of opioids
0.000 0.987 0.013
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine
0.000 0.987 0.013
J34 Other disorders of nose and nasal sinuses
0.000 0.987 0.013
F18 Mental and behavioural disorders due to use of volatile solvents
0.000 0.988 0.012
F16 Mental and behavioural disorders due to use of hallucinogens
0.000 0.988 0.012
F14 Mental and behavioural disorders due to use of cocaine
0.000 0.988 0.012
H61.8 Other specified disorders of external ear
0.000 0.988 0.012
H61 Other disorders of external ear
0.000 0.988 0.012
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances
0.000 0.988 0.012
J30 Vasomotor and allergic rhinitis
0.000 0.988 0.012
J32.9 Chronic sinusitis, unspecified
0.000 0.988 0.012
G55.2 Nerve root and plexus compressions in spondylosis
0.012 0.988 0.000
J33.1 Polypoid sinus degeneration
0.000 0.989 0.011
F13 Mental and behavioural disorders due to use of sedatives or hypnotics
0.000 0.989 0.011
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.989 0.011
D86.0 Sarcoidosis of lung
0.011 0.989 0.000
J32.4 Chronic pansinusitis
0.000 0.989 0.011
J30.1 Allergic rhinitis due to pollen
0.000 0.989 0.011
F11.1 Harmful use
0.000 0.989 0.010
J32.1 Chronic frontal sinusitis
0.000 0.990 0.010
F11.2 Dependence syndrome
0.000 0.990 0.010
J30.4 Allergic rhinitis, unspecified
0.000 0.990 0.010
J32.2 Chronic ethmoidal sinusitis
0.000 0.990 0.010
J32.3 Chronic sphenoidal sinusitis
0.000 0.990 0.010
H61.9 Disorder of external ear, unspecified
0.000 0.990 0.010
D86.9 Sarcoidosis, unspecified
0.010 0.990 0.000
F15.1 Harmful use
0.000 0.990 0.010
T40.6 Other and unspecified narcotics
0.000 0.990 0.010
F19.1 Harmful use
0.000 0.990 0.010
F11.9 Unspecified mental and behavioural disorder
0.000 0.990 0.010
F11.8 Other mental and behavioural disorders
0.000 0.990 0.010
F11.7 Residual and late-onset psychotic disorder
0.000 0.990 0.010
F11.6 Amnesic syndrome
0.000 0.990 0.010
F11.5 Psychotic disorder
0.000 0.990 0.010
F11.4 Withdrawal state with delirium
0.000 0.990 0.010
F11.0 Acute intoxication
0.000 0.990 0.010
J37 Chronic laryngitis and laryngotracheitis
0.000 0.990 0.010
J34.2 Deviated nasal septum
0.000 0.990 0.010
F12 Mental and behavioural disorders due to use of cannabinoids
0.001 0.990 0.009
J34.0 Abscess, furuncle and carbuncle of nose
0.000 0.990 0.010
J30.0 Vasomotor rhinitis
0.000 0.991 0.009
D86 Sarcoidosis
0.009 0.991 0.000
F15.9 Unspecified mental and behavioural disorder
0.000 0.991 0.009
F15.8 Other mental and behavioural disorders
0.000 0.991 0.009
F15.7 Residual and late-onset psychotic disorder
0.000 0.991 0.009
F15.6 Amnesic syndrome
0.000 0.991 0.009
F15.5 Psychotic disorder
0.000 0.991 0.009
F15.4 Withdrawal state with delirium
0.000 0.991 0.009
F15.3 Withdrawal state
0.000 0.991 0.009
F15.2 Dependence syndrome
0.000 0.991 0.009
F15.0 Acute intoxication
0.000 0.991 0.009
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.991 0.009
I24.8 Other forms of acute ischaemic heart disease
0.009 0.991 0.000
F11.3 Withdrawal state
0.000 0.991 0.009
F14.9 Unspecified mental and behavioural disorder
0.000 0.991 0.009
F14.8 Other mental and behavioural disorders
0.000 0.991 0.009
F14.7 Residual and late-onset psychotic disorder
0.000 0.991 0.009
F14.6 Amnesic syndrome
0.000 0.991 0.009
F14.5 Psychotic disorder
0.000 0.991 0.009
F14.4 Withdrawal state with delirium
0.000 0.991 0.009
F14.3 Withdrawal state
0.000 0.991 0.009
F14.2 Dependence syndrome
0.000 0.991 0.009
F14.1 Harmful use
0.000 0.991 0.009
F14.0 Acute intoxication
0.000 0.991 0.009
F16.9 Unspecified mental and behavioural disorder
0.000 0.991 0.009
F16.8 Other mental and behavioural disorders
0.000 0.991 0.009
F16.7 Residual and late-onset psychotic disorder
0.000 0.991 0.009
F16.6 Amnesic syndrome
0.000 0.991 0.009
F16.5 Psychotic disorder
0.000 0.991 0.009
F16.4 Withdrawal state with delirium
0.000 0.991 0.009
F16.3 Withdrawal state
0.000 0.991 0.009
F16.2 Dependence syndrome
0.000 0.991 0.009
F16.1 Harmful use
0.000 0.991 0.009
F16.0 Acute intoxication
0.000 0.991 0.009
F18.9 Unspecified mental and behavioural disorder
0.000 0.991 0.009
F18.8 Other mental and behavioural disorders
0.000 0.991 0.009
F18.7 Residual and late-onset psychotic disorder
0.000 0.991 0.009
F18.6 Amnesic syndrome
0.000 0.991 0.009
F18.5 Psychotic disorder
0.000 0.991 0.009
F18.4 Withdrawal state with delirium
0.000 0.991 0.009
F18.3 Withdrawal state
0.000 0.991 0.009
F18.2 Dependence syndrome
0.000 0.991 0.009
F18.1 Harmful use
0.000 0.991 0.009
F18.0 Acute intoxication
0.000 0.991 0.009
J36 Peritonsillar abscess
0.000 0.991 0.009
J39.8 Other specified diseases of upper respiratory tract
0.000 0.991 0.009
F19.9 Unspecified mental and behavioural disorder
0.000 0.991 0.009
F19.8 Other mental and behavioural disorders
0.000 0.991 0.009
F19.7 Residual and late-onset psychotic disorder
0.000 0.991 0.009
F19.6 Amnesic syndrome
0.000 0.991 0.009
F19.5 Psychotic disorder
0.000 0.991 0.009
F19.4 Withdrawal state with delirium
0.000 0.991 0.009
F19.3 Withdrawal state
0.000 0.991 0.009
F19.0 Acute intoxication
0.000 0.991 0.009
J35 Chronic diseases of tonsils and adenoids
0.000 0.991 0.009
H61.3 Acquired stenosis of external ear canal
0.000 0.991 0.009
J39 Other diseases of upper respiratory tract
0.000 0.991 0.009
J34.1 Cyst and mucocele of nose and nasal sinus
0.000 0.991 0.009
I84.1 Internal haemorrhoids with other complications
0.000 0.992 0.008
F13.9 Unspecified mental and behavioural disorder
0.000 0.992 0.008
F13.8 Other mental and behavioural disorders
0.000 0.992 0.008
F13.7 Residual and late-onset psychotic disorder
0.000 0.992 0.008
F13.6 Amnesic syndrome
0.000 0.992 0.008
F13.5 Psychotic disorder
0.000 0.992 0.008
F13.4 Withdrawal state with delirium
0.000 0.992 0.008
F13.3 Withdrawal state
0.000 0.992 0.008
F13.1 Harmful use
0.000 0.992 0.008
F13.0 Acute intoxication
0.000 0.992 0.008
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.992 0.008
T40.8 Lysergide [LSD]
0.000 0.992 0.008
T40.7 Cannabis (derivatives)
0.000 0.992 0.008
T40.3 Methadone
0.000 0.992 0.008
T40.0 Opium
0.000 0.992 0.008
J30.3 Other allergic rhinitis
0.000 0.992 0.008
A04.5 Campylobacter enteritis
0.008 0.992 0.000
J33.9 Nasal polyp, unspecified
0.000 0.992 0.008
D86.3 Sarcoidosis of skin
0.008 0.992 0.000
D86.8 Sarcoidosis of other and combined sites
0.008 0.992 0.000
F12.2 Dependence syndrome
0.000 0.992 0.007
F17 Mental and behavioural disorders due to use of tobacco
0.000 0.992 0.008
T39.0 Salicylates
0.000 0.993 0.007
J30.2 Other seasonal allergic rhinitis
0.000 0.993 0.007
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.993 0.007
J35.9 Chronic disease of tonsils and adenoids, unspecified
0.000 0.993 0.007
F13.2 Dependence syndrome
0.000 0.993 0.007
J37.1 Chronic laryngotracheitis
0.000 0.993 0.007
T40.5 Cocaine
0.000 0.993 0.007
F12.9 Unspecified mental and behavioural disorder
0.001 0.993 0.007
F12.8 Other mental and behavioural disorders
0.001 0.993 0.007
F12.7 Residual and late-onset psychotic disorder
0.001 0.993 0.007
F12.6 Amnesic syndrome
0.001 0.993 0.007
F12.5 Psychotic disorder
0.001 0.993 0.007
F12.4 Withdrawal state with delirium
0.001 0.993 0.007
F12.3 Withdrawal state
0.001 0.993 0.007
F12.0 Acute intoxication
0.001 0.993 0.007
J35.8 Other chronic diseases of tonsils and adenoids
0.000 0.993 0.007
J37.0 Chronic laryngitis
0.000 0.993 0.007
F19.2 Dependence syndrome
0.000 0.993 0.007
T40.1 Heroin
0.000 0.993 0.007
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes
0.007 0.993 0.000
S52.00 Fracture of upper end of ulna (closed)
0.000 0.993 0.007
S52.0 Fracture of upper end of ulna
0.000 0.993 0.007
J32.8 Other chronic sinusitis
0.000 0.993 0.007
H61.1 Non-infective disorders of pinna
0.000 0.993 0.006
J35.3 Hypertrophy of tonsils with hypertrophy of adenoids
0.000 0.993 0.006
J39.3 Upper respiratory tract hypersensitivity reaction, site unspecified
0.000 0.993 0.006
S52.01 Fracture of upper end of ulna (open)
0.000 0.994 0.006
J35.2 Hypertrophy of adenoids
0.000 0.994 0.006
J35.1 Hypertrophy of tonsils
0.000 0.994 0.006
J31 Chronic rhinitis, nasopharyngitis and pharyngitis
0.000 0.994 0.006
S52.10 Fracture of upper end of radius (closed)
0.000 0.994 0.006
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.994 0.006
E87.2 Acidosis
0.000 0.994 0.006
J39.9 Disease of upper respiratory tract, unspecified
0.000 0.994 0.006
T43.6 Psychostimulants with abuse potential
0.000 0.994 0.006
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.994 0.006
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.994 0.006
J39.0 Retropharyngeal and parapharyngeal abscess
0.000 0.994 0.006
S52.1 Fracture of upper end of radius
0.000 0.994 0.006
S52 Fracture of forearm
0.000 0.994 0.006
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.994 0.006
J39.1 Other abscess of pharynx
0.000 0.994 0.005
F17.9 Unspecified mental and behavioural disorder
0.000 0.994 0.006
F17.8 Other mental and behavioural disorders
0.000 0.994 0.006
F17.7 Residual and late-onset psychotic disorder
0.000 0.994 0.006
F17.6 Amnesic syndrome
0.000 0.994 0.006
F17.5 Psychotic disorder
0.000 0.994 0.006
F17.4 Withdrawal state with delirium
0.000 0.994 0.006
F17.0 Acute intoxication
0.000 0.994 0.006
S52.5 Fracture of lower end of radius
0.000 0.994 0.006
T40.4 Other synthetic narcotics
0.000 0.994 0.005
T43.9 Psychotropic drug, unspecified
0.000 0.994 0.005
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.994 0.005
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.994 0.005
M65.95 Synovitis and tenosynovitis, unspecified (Pelvic region and thigh)
0.006 0.994 0.000
M90.75 Fracture of bone in neoplastic disease (Pelvic region and thigh)
0.000 0.994 0.005
J34.3 Hypertrophy of nasal turbinates
0.000 0.995 0.005
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.995 0.005
F17.3 Withdrawal state
0.000 0.995 0.005
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.995 0.005
T36 Poisoning by systemic antibiotics
0.000 0.995 0.005
S52.51 Fracture of lower end of radius (open)
0.000 0.995 0.005
S52.50 Fracture of lower end of radius (closed)
0.000 0.995 0.005
D86.1 Sarcoidosis of lymph nodes
0.005 0.995 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.995 0.005
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.995 0.005
S52.4 Fracture of shafts of both ulna and radius
0.000 0.995 0.005
J31.1 Chronic nasopharyngitis
0.000 0.995 0.005
F17.1 Harmful use
0.000 0.995 0.005
M65.96 Synovitis and tenosynovitis, unspecified (Lower leg)
0.005 0.995 0.000
M90.78 Fracture of bone in neoplastic disease (Other)
0.000 0.995 0.005
M13.93 Arthritis, unspecified (Forearm)
0.005 0.995 0.000
M90.7 Fracture of bone in neoplastic disease
0.000 0.995 0.004
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.995 0.005
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.995 0.004
T83.1 Mechanical complication of other urinary devices and implants
0.000 0.995 0.005
S52.11 Fracture of upper end of radius (open)
0.000 0.995 0.004
J31.2 Chronic pharyngitis
0.000 0.995 0.004
S52.9 Fracture of forearm, part unspecified
0.000 0.996 0.004
T36.0 Penicillins
0.000 0.996 0.004
T39.4 Antirheumatics, not elsewhere classified
0.000 0.996 0.004
T39.2 Pyrazolone derivatives
0.000 0.996 0.004
S52.7 Multiple fractures of forearm
0.000 0.996 0.004
M65.9 Synovitis and tenosynovitis, unspecified
0.004 0.996 0.000
T43.2 Other and unspecified antidepressants
0.000 0.996 0.004
S52.40 Fracture of shafts of both ulna and radius (closed)
0.000 0.996 0.004
M65.94 Synovitis and tenosynovitis, unspecified (Hand)
0.004 0.996 0.000
S89.9 Unspecified injury of lower leg
0.004 0.996 0.000
I61.9 Intracerebral haemorrhage, unspecified
0.000 0.996 0.004
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.996 0.004
S52.6 Fracture of lower end of both ulna and radius
0.000 0.996 0.004
S52.3 Fracture of shaft of radius
0.000 0.996 0.004
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.996 0.004
I97.2 Postmastectomy lymphoedema syndrome
0.004 0.996 0.000
T50.8 Diagnostic agents
0.000 0.996 0.004
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.996 0.004
S52.8 Fracture of other parts of forearm
0.000 0.996 0.004
T50.7 Analeptics and opioid receptor antagonists
0.000 0.996 0.004
T50.5 Appetite depressants
0.000 0.996 0.004
T50.4 Drugs affecting uric acid metabolism
0.000 0.996 0.004
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.996 0.004
T50.1 Loop [high-ceiling] diuretics
0.000 0.996 0.004
T50.0 Mineralocorticoids and their antagonists
0.000 0.996 0.004
M70.65 Trochanteric bursitis-Pelvic/Thigh
0.004 0.996 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.996 0.004
S52.2 Fracture of shaft of ulna
0.000 0.996 0.004
T36.9 Systemic antibiotic, unspecified
0.000 0.996 0.004
T36.8 Other systemic antibiotics
0.000 0.996 0.004
T36.7 Antifungal antibiotics, systemically used
0.000 0.996 0.004
T36.6 Rifamycins
0.000 0.996 0.004
T36.5 Aminoglycosides
0.000 0.996 0.004
T36.4 Tetracyclines
0.000 0.996 0.004
T36.3 Macrolides
0.000 0.996 0.004
T36.2 Chloramphenicol group
0.000 0.996 0.004
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.996 0.004
F12.1 Harmful use
0.001 0.996 0.002
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.996 0.004
Z57.2 Occupational exposure to dust
0.004 0.996 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.996 0.004
M65.93 Synovitis and tenosynovitis, unspecified (Forearm)
0.004 0.996 0.000
N41.9 Inflammatory disease of prostate, unspecified
0.004 0.996 0.000
F17.2 Dependence syndrome
0.000 0.996 0.004
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.996 0.003
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.996 0.003
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.996 0.003
S52.41 Fracture of shafts of both ulna and radius (open)
0.000 0.996 0.003
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.996 0.003
T37.5 Antiviral drugs
0.000 0.996 0.003
T37.4 Anthelminthics
0.000 0.996 0.003
T37.3 Other antiprotozoal drugs
0.000 0.996 0.003
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.996 0.003
T37.1 Antimycobacterial drugs
0.000 0.996 0.003
T37.0 Sulphonamides
0.000 0.996 0.003
M90.79 Fracture of bone in neoplastic disease (Site unspecified)
0.000 0.996 0.003
M90.77 Fracture of bone in neoplastic disease (Ankle and foot)
0.000 0.996 0.003
M90.76 Fracture of bone in neoplastic disease (Lower leg)
0.000 0.996 0.003
M90.74 Fracture of bone in neoplastic disease (Hand)
0.000 0.996 0.003
M90.73 Fracture of bone in neoplastic disease (Forearm)
0.000 0.996 0.003
M90.70 Fracture of bone in neoplastic disease (Multiple sites)
0.000 0.996 0.003
H60-H62 Diseases of external ear
0.000 0.996 0.004
M90.72 Fracture of bone in neoplastic disease (Upper arm)
0.000 0.996 0.003
T41.5 Therapeutic gases
0.000 0.996 0.003
T41.4 Anaesthetic, unspecified
0.000 0.996 0.003
T41.3 Local anaesthetics
0.000 0.996 0.003
T41.2 Other and unspecified general anaesthetics
0.000 0.996 0.003
T41.1 Intravenous anaesthetics
0.000 0.996 0.003
T41.0 Inhaled anaesthetics
0.000 0.996 0.003
M65.99 Synovitis and tenosynovitis, unspecified (Site unspecified)
0.003 0.996 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.996 0.003
S52.91 Fracture of forearm, part unspecified (open)
0.000 0.997 0.003
S52.90 Fracture of forearm, part unspecified (closed)
0.000 0.997 0.003
S52.71 Multiple fractures of forearm (open)
0.000 0.997 0.003
M65.98 Synovitis and tenosynovitis, unspecified (Other)
0.003 0.997 0.000
M90.71 Fracture of bone in neoplastic disease (Shoulder region)
0.000 0.997 0.003
S52.61 Fracture of lower end of both ulna and radius (open)
0.000 0.997 0.003
F43.2 Adjustment disorders
0.000 0.997 0.003
K70.9 Alcoholic liver disease, unspecified
0.000 0.997 0.003
S52.70 Multiple fractures of forearm (closed)
0.000 0.997 0.003
Z88.8 Personal history of allergy to other drugs, medicaments and biological substances
0.003 0.997 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.997 0.003
T48.5 Anti-common-cold drugs
0.000 0.997 0.003
T48.4 Expectorants
0.000 0.997 0.003
T48.3 Antitussives
0.000 0.997 0.003
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.997 0.003
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.997 0.003
T48.0 Oxytocic drugs
0.000 0.997 0.003
S52.31 Fracture of shaft of radius (open)
0.000 0.997 0.003
E89.0 Postprocedural hypothyroidism
0.000 0.997 0.003
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.997 0.003
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.997 0.003
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.997 0.003
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.997 0.003
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.997 0.003
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.997 0.003
T44.0 Anticholinesterase agents
0.000 0.997 0.003
I97.8 Other postprocedural disorders of circulatory system, not elsewhere classified
0.003 0.997 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.997 0.003
M17 Gonarthrosis [arthrosis of knee]
0.003 0.997 0.000
S52.21 Fracture of shaft of ulna (open)
0.000 0.997 0.003
T49.9 Topical agent, unspecified
0.000 0.997 0.003
T49.8 Other topical agents
0.000 0.997 0.003
T49.7 Dental drugs, topically applied
0.000 0.997 0.003
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.997 0.003
T49.5 Ophthalmological drugs and preparations
0.000 0.997 0.003
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.997 0.003
T49.3 Emollients, demulcents and protectants
0.000 0.997 0.003
T49.2 Local astringents and local detergents
0.000 0.997 0.003
T49.1 Antipruritics
0.000 0.997 0.003
M65.90 Synovitis and tenosynovitis, unspecified (Multiple sites)
0.003 0.997 0.000
S52.81 Fracture of other parts of forearm (open)
0.000 0.997 0.003
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.997 0.003
K08.9 Disorder of teeth and supporting structures, unspecified
0.000 0.997 0.003
M65.92 Synovitis and tenosynovitis, unspecified (Upper arm)
0.003 0.997 0.000
I61 Intracerebral haemorrhage
0.000 0.997 0.003
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.997 0.003
I61.4 Intracerebral haemorrhage in cerebellum
0.000 0.997 0.003
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.997 0.003
I61.2 Intracerebral haemorrhage in hemisphere, unspecified
0.000 0.997 0.003
I61.0 Intracerebral haemorrhage in hemisphere, subcortical
0.000 0.997 0.003
M77.02 Medial epicondylitis (Upper arm)
0.003 0.997 0.000
M47.22 Other spondylosis with radiculopathy (Cervical region)
0.003 0.997 0.000
T45.2 Vitamins, not elsewhere classified
0.000 0.997 0.003
S52.30 Fracture of shaft of radius (closed)
0.000 0.997 0.003
T39.1 4-Aminophenol derivatives
0.000 0.997 0.003
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.997 0.003
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.997 0.003
T47.7 Emetics
0.000 0.997 0.003
T47.5 Digestants
0.000 0.997 0.003
T47.3 Saline and osmotic laxatives
0.000 0.997 0.003
I97 Postprocedural disorders of circulatory system, not elsewhere classified
0.003 0.997 0.000
K26.4 Chronic or unspecified with haemorrhage
0.000 0.997 0.003
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.997 0.003
Z88.9 Personal history of allergy to unspecified drugs, medicaments and biological substances
0.003 0.997 0.000
K76.9 Liver disease, unspecified
0.000 0.997 0.003
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.997 0.003
T38.9 Other and unspecified hormone antagonists
0.000 0.997 0.003
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.997 0.003
T38.7 Androgens and anabolic congeners
0.000 0.997 0.003
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.997 0.003
T38.5 Other oestrogens and progestogens
0.000 0.997 0.003
T38.4 Oral contraceptives
0.000 0.997 0.003
T38.2 Antithyroid drugs
0.000 0.997 0.003
T38.0 Glucocorticoids and synthetic analogues
0.000 0.997 0.003
H62 Disorders of external ear in diseases classified elsewhere
0.000 0.997 0.003
H61.2 Impacted cerumen
0.000 0.997 0.003
T47.4 Other laxatives
0.000 0.997 0.003
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.997 0.002
T45.8 Other primarily systemic and haematological agents
0.000 0.997 0.002
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.997 0.002
T45.6 Fibrinolysis-affecting drugs
0.000 0.997 0.002
T45.4 Iron and its compounds
0.000 0.997 0.002
T45.3 Enzymes, not elsewhere classified
0.000 0.997 0.002
T47.0 Histamine H(2)-receptor antagonists
0.000 0.997 0.003
T83.0 Mechanical complication of urinary (indwelling) catheter
0.000 0.997 0.003
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.997 0.003
M65.97 Synovitis and tenosynovitis, unspecified (Ankle and foot)
0.003 0.997 0.000
S79.9 Unspecified injury of hip and thigh
0.000 0.997 0.003
T38.1 Thyroid hormones and substitutes
0.000 0.997 0.002
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.997 0.002
S52.80 Fracture of other parts of forearm (closed)
0.000 0.997 0.003
S52.60 Fracture of lower end of both ulna and radius (closed)
0.000 0.997 0.003
T47.2 Stimulant laxatives
0.000 0.997 0.002
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.997 0.003
T83.6 Infection and inflammatory reaction due to prosthetic device, implant and graft in genital tract
0.000 0.997 0.003
M17.2 Posttraumatic gonarthrosis, bilateral
0.002 0.997 0.000
T83.4 Mechanical complication of other prosthetic devices, implants and grafts in genital tract
0.000 0.997 0.003
I61.8 Other intracerebral haemorrhage
0.000 0.997 0.003
M47.2 Other spondylosis with radiculopathy
0.003 0.997 0.000
T47.6 Antidiarrhoeal drugs
0.000 0.997 0.002
T83 Complications of genito-urinary prosthetic devices, implants and grafts
0.000 0.997 0.003
M47.26 Other spondylosis with radiculopathy (Lumbar region)
0.003 0.997 0.000
M70.6 Trochanteric bursitis
0.002 0.997 0.000
M90 Osteopathies in diseases classified elsewhere
0.000 0.997 0.002
D80-D89 Certain disorders involving the immune mechanism
0.002 0.997 0.000
S52.20 Fracture of shaft of ulna (closed)
0.000 0.998 0.002
I61.6 Intracerebral haemorrhage, multiple localised
0.000 0.998 0.002
M17.3 Other posttraumatic gonarthrosis
0.002 0.998 0.000
M24.17 Other articular cartilage disorders (Ankle and foot)
0.002 0.998 0.000
S62.40 Multiple fractures of metacarpal bones (closed)
0.000 0.998 0.002
J35.0 Chronic tonsillitis
0.000 0.998 0.002
M96.0 Pseudarthrosis after fusion or arthrodesis
0.002 0.998 0.000
M47.27 Other spondylosis with radiculopathy (Lumbosacral region)
0.002 0.998 0.000
K76.8 Other specified diseases of liver
0.000 0.998 0.002
G93.0 Cerebral cysts
0.002 0.998 0.000
H62.0 Otitis externa in bacterial diseases classified elsewhere
0.000 0.998 0.002
I97.9 Postprocedural disorder of circulatory system, unspecified
0.002 0.998 0.000
I97.0 Postcardiotomy syndrome
0.002 0.998 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.998 0.002
Z57 Occupational exposure to risk-factors
0.002 0.998 0.000
S92.10 Fracture of talus (closed)
0.002 0.998 0.000
H62.8 Other disorders of external ear in diseases classified elsewhere
0.000 0.998 0.002
H62.4 Otitis externa in other diseases classified elsewhere
0.000 0.998 0.002
H62.3 Otitis externa in other infectious and parasitic diseases classified elsewhere
0.000 0.998 0.002
H62.2 Otitis externa in mycoses
0.000 0.998 0.002
H62.1 Otitis externa in viral diseases classified elsewhere
0.000 0.998 0.002
E80.4 Gilbert's syndrome
0.000 0.998 0.002
Z91.6 Personal history of other physical trauma
0.000 0.998 0.002
M89.84 Other specified disorders of bone (Hand)
0.002 0.998 0.000
K70 Alcoholic liver disease
0.000 0.998 0.002
I61.3 Intracerebral haemorrhage in brain stem
0.000 0.998 0.002
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.998 0.002
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.998 0.002
T46.7 Peripheral vasodilators
0.000 0.998 0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.998 0.002
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.998 0.002
Z57.5 Occupational exposure to toxic agents in other industries
0.002 0.998 0.000
K70.1 Alcoholic hepatitis
0.000 0.998 0.002
K70.0 Alcoholic fatty liver
0.000 0.998 0.002
I61.1 Intracerebral haemorrhage in hemisphere, cortical
0.000 0.998 0.002
D83 Common variable immunodeficiency
0.002 0.998 0.000
M07.39 Other psoriatic arthropathies (Site unspecified)
0.000 0.998 0.002
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.998 0.002
M47.20 Other spondylosis with radiculopathy (Multiple sites in spine)
0.002 0.998 0.000
E89.2 Postprocedural hypoparathyroidism
0.000 0.998 0.002
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.998 0.002
T45.5 Anticoagulants
0.001 0.998 0.001
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.998 0.002
M47.29 Other spondylosis with radiculopathy (Site unspecified)
0.002 0.998 0.000
M47.28 Other spondylosis with radiculopathy (Sacral and sacrococcygeal region)
0.002 0.998 0.000
M47.25 Other spondylosis with radiculopathy (Thoracolumbar region)
0.002 0.998 0.000
M47.24 Other spondylosis with radiculopathy (Thoracic region)
0.002 0.998 0.000
M47.23 Other spondylosis with radiculopathy (Cervicothoracic region)
0.002 0.998 0.000
M47.21 Other spondylosis with radiculopathy (Occipito-atlanto-axial region)
0.002 0.998 0.000
M90.1 Periostitis in other infectious diseases classified elsewhere
0.000 0.998 0.002
S83.2 Tear of meniscus, current
0.002 0.998 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.998 0.002
T46.1 Calcium-channel blockers
0.000 0.998 0.002
M70.69 Trochanteric bursitis-Site unspec
0.002 0.998 0.000
M70.68 Trochanteric bursitis-Other
0.002 0.998 0.000
M70.67 Trochanteric bursitis-Ankle/Foot
0.002 0.998 0.000
M70.66 Trochanteric bursitis-Lower Leg
0.002 0.998 0.000
M70.64 Trochanteric bursitis-Hand
0.002 0.998 0.000
M70.63 Trochanteric bursitis-Forearm
0.002 0.998 0.000
M70.62 Trochanteric bursitis-Upper arm
0.002 0.998 0.000
M70.61 Trochanteric bursitis-Shldr region
0.002 0.998 0.000
M70.60 Trochanteric bursitis-Mult sites
0.002 0.998 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.998 0.002
M90.8 Osteopathy in other diseases classified elsewhere
0.000 0.998 0.002
M90.6 Osteitis deformans in neoplastic disease
0.000 0.998 0.002
M90.5 Osteonecrosis in other diseases classified elsewhere
0.000 0.998 0.002
M90.4 Osteonecrosis due to heamoglobinopathy
0.000 0.998 0.002
M90.3 Osteonecrosis in caisson disease
0.000 0.998 0.002
M90.2 Osteopathy in other infectious diseases classified elsewhere
0.000 0.998 0.002
M90.0 Tuberculosis of bone
0.000 0.998 0.002
R09.2 Respiratory arrest
0.000 0.998 0.002
Z57.8 Occupational exposure to other risk-factors
0.002 0.998 0.000
D82 Immunodeficiency associated with other major defects
0.002 0.998 0.000
D81 Combined immunodeficiencies
0.002 0.998 0.000
M89.86 Other specified disorders of bone (Lower leg)
0.002 0.998 0.000
S89 Other and unspecified injuries of lower leg
0.002 0.998 0.000
C69.3 Choroid
0.000 0.998 0.002
I97.1 Other functional disturbances following cardiac surgery
0.002 0.998 0.000
K70.2 Alcoholic fibrosis and sclerosis of liver
0.000 0.998 0.002
M17.4 Other secondary gonarthrosis, bilateral
0.002 0.998 0.000
T21.3 Burn of third degree of trunk
0.002 0.998 0.000
T42.1 Iminostilbenes
0.000 0.998 0.002
D84 Other immunodeficiencies
0.002 0.998 0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.000 0.998 0.002
S62.50 Fracture of thumb (closed)
0.000 0.998 0.002
L57.8 Other skin changes due to chronic exposure to nonionising radiation
0.002 0.998 0.000
M17.5 Other secondary gonarthrosis
0.002 0.998 0.000
M25.78 Osteophyte (Other)
0.002 0.998 0.000
D83.9 Common variable immunodeficiency, unspecified
0.002 0.998 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.998 0.002
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.998 0.002
T42.3 Barbiturates
0.000 0.998 0.002
T42.2 Succinimides and oxazolidinediones
0.000 0.998 0.002
Z57.9 Occupational exposure to unspecified risk-factor
0.002 0.998 0.000
Z57.7 Occupational exposure to vibration
0.002 0.998 0.000
Z57.6 Occupational exposure to extreme temperature
0.002 0.998 0.000
Z57.4 Occupational exposure to toxic agents in agriculture
0.002 0.998 0.000
Z57.1 Occupational exposure to radiation
0.002 0.998 0.000
Z57.0 Occupational exposure to noise
0.002 0.998 0.000
M00.91 Pyogenic arthritis, unspecified (Shoulder region)
0.002 0.998 0.000
T42.0 Hydantoin derivatives
0.000 0.998 0.002
R03.1 Nonspecific low blood-pressure reading
0.002 0.998 0.000
M24.16 Other articular cartilage disorders (Lower leg)
0.002 0.998 0.000
E89.3 Postprocedural hypopituitarism
0.000 0.998 0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.